Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,910.00
-19.05 (-0.99%)
BSENSE

Oct 09

BSE+NSE Vol: 97.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,910.00",
    "chg": -19.05,
    "chgp": "-0.99%",
    "dir": -1,
    "prev_price": "1,929.05",
    "mcapval": "48,832.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "97.07 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-08 14:31:29",
        "description": "Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price  Livemint..."
      }
    ],
    "total": 1,
    "sid": "950228",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Sep-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "17-Aug-2026",
      "details": "Transcript of Conference Call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Aug-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>600%</strong> dividend, ex-date: 07 Aug 26",
          "dt": "2026-08-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Closure of Trading Window

22-Sep-2026 | Source : BSE

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

17-Aug-2026 | Source : BSE

Transcript of Conference Call

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Aug-2026 | Source : BSE

Copy of Newspaper Publication

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Ipca Laboratories Ltd has declared 600% dividend, ex-date: 07 Aug 26

stock-summary
SPLITS

Ipca Laboratories Ltd has announced 1:2 stock split, ex-date: 10 Jan 22

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available